Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nephros raises $5m in private money:

This article was originally published in Clinica

Executive Summary

New York-based renal disease therapy company Nephros has raised $5m following the sale of secured convertible notes to several investors. The proceeds will be used to fund product development and marketing and to provide working capital for commercialising its new water filtration technology. The company develops dialysis devices for patients suffering from end-stage renal disease; its latest water filtration device is designed to remove a broad range of bacteria, viral agents and toxic substances including - among others - salmonella, HIV, hepatitis and E coli.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT051911

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel